Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbiopharmadive.com
BioPharma Dive - Latest News
Get the latest updates from BioPharma Dive - Latest News directly as they happen.
Follow now 148 followers
Latest posts
Last updated 2 days ago
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
3 days ago
In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor...
Summit pulls $500M share sale a day after announcing it
3 days ago
The developer of a leading PD-1/VEGF cancer drug cited “market conditions” for...
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
3 days ago
A strategic review determined that the development environment had "notably changed," leading...
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
4 days ago
The data showed that del-brax, an “antisense oligonucleotide conjugate” being tested against...
J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
4 days ago
New data suggest Imaavy could be an effective treatment for autoimmune anemia...
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
4 days ago
The results support Takeda’s long-held belief in zasocitinib’s superiority and could help...
Ethyreal starts up with $101M and takes aim at a pair of immune diseases
4 days ago
The startup is developing a medicine that works differently than available treatments...
Sanofi stops immune drug trial in latest research setback
4 days ago
The failure adds to a series of mixed or negative readouts and...
Parabilis sets a record with a $670M biotech IPO
5 days ago
The largest-ever new stock sale for a venture-backed biotech company extends a...
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
5 days ago
Newly published data convinced AstraZeneca to conduct a sprawling late-stage program for...
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
5 days ago
Trodelvy's latest setback carries implications for a newly important Merck drug, while...
Stealthy startup Treeline plans a reverse merger
5 days ago
Led by former Loxo Oncology CEO Josh Bilenker, the startup now has...